Search

Search Constraints

You searched for: Author/Creator Nishimura, Michael

Search Results

1. The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study. (4th November 2015)

2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

3. Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion. (7th November 2013)

4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

5. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

6. The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study. Issue 2 (December 2015)

7. Human CD36hi monocytes induce Foxp3+ CD25+ T cells with regulatory functions from CD4 and CD8 subsets. Issue 3 (7th March 2021)